Kim, Kidong <br/><br/>
XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer.  [electronic resource] 

 -  Gynecologic oncology  Dec 2008 
 - 509-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1095-6859 
<br/><br/><label>Standard No.: </label>10.1016/j.ygyno.2008.08.034  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carboplatin--administration & dosage<br/>Chemotherapy, Adjuvant<br/>Cisplatin--administration & dosage<br/>DNA-Binding Proteins--genetics<br/>Epirubicin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Glutathione S-Transferase pi--genetics<br/>Humans<br/>Interferon-gamma--administration & dosage<br/>Methylenetetrahydrofolate Dehydrogenase (NADP)--genetics<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Paclitaxel--administration & dosage<br/>Polymorphism, Single Nucleotide<br/>Retrospective Studies<br/>Uterine Cervical Neoplasms--drug therapy<br/>X-ray Repair Cross Complementing Protein 1<br/>gamma-Glutamyl Hydrolase--genetics